[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:diffuse-midline-glioma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":178,"states":195},"Diffuse Midline Glioma",27,24,[8,16,23,29,35,41,47,53,59,66,72,78,84,90,96,102,108,114,120,127,133,139,145,151,157,164,171],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05077735","Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Trial",[12],"Phase 2","RECRUITING","2026-08-26T02:14:59.425132Z","2026-07-19T19:36:05.115026Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT04943848","rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG",[20],"Phase 1","2026-08-26T02:16:10.529598Z","2026-05-05T02:43:28.983532Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07076498","Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation",[20],"2026-08-26T02:16:36.513735Z","2026-05-05T02:43:27.816834Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT04196413","GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)",[20],"2026-08-26T02:17:41.695983Z","2026-05-05T02:43:27.416742Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT05762419","FUS Etoposide for DMG",[20],"2026-08-26T02:17:01.714035Z","2026-05-05T02:43:27.055633Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT03988283","Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors",[20],"2026-08-26T02:19:28.327680Z","2026-07-05T05:32:16.792431Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT06894979","Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma",[20],"2026-08-03T00:59:21.983893Z","2026-07-05T05:32:16.705849Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT06305910","CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG\u002FDIPG in Children and Young Adults",[20],"2026-08-26T02:16:01.079019Z","2026-05-05T02:43:29.586016Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":64,"content_modified":65},"NCT05099003","A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)",[63],"Phase 1\u002FPhase 2","2026-08-26T02:15:28.524219Z","2026-05-05T02:43:28.532137Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT05009992","Combination Therapy for the Treatment of Diffuse Midline Gliomas",[12],"2026-08-26T02:16:51.982021Z","2026-05-05T02:43:28.301737Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT06624371","Atovaquone Combined With Radiation in Children With Malignant Brain Tumors",[20],"2026-08-26T02:15:13.282904Z","2026-05-05T02:35:31.758752Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT06639607","PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma\u002FHigh-grade Glioma and Recurrent Diffuse Midline Glioma\u002FHigh-grade Glioma, Medulloblastoma, and Ependymoma",[63],"2026-08-03T00:58:26.564367Z","2026-07-05T05:32:16.689130Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT07223034","A Study of 177Lu-PSMA-617 in People With Gliomas",[20],"2026-08-26T02:16:23.080181Z","2026-07-05T05:32:16.669055Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT04732065","ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors",[20],"2026-08-26T02:19:08.862440Z","2026-05-05T02:43:29.325044Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT04541082","Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms",[20],"2026-08-26T02:18:37.277498Z","2026-05-05T02:43:29.163334Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":106,"content_modified":107},"NCT04185038","Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma\u002FDiffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors",[20],"2026-08-26T02:18:51.833592Z","2026-05-05T02:43:28.903254Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":112,"content_modified":113},"NCT04870944","CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma",[63],"2026-08-03T02:31:11.254845Z","2026-05-05T02:43:27.478011Z",{"nct_id":115,"title":116,"phases":117,"status":13,"updated_at":118,"content_modified":119},"NCT04099797","C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)",[20],"2026-08-26T02:16:22.235886Z","2026-05-05T02:43:27.089113Z",{"nct_id":121,"title":122,"phases":123,"status":13,"updated_at":125,"content_modified":126},"NCT05553041","18F-Fluciclovine PET-MRI in High-grade Glioma",[124],"Early Phase 1","2026-08-26T02:18:06.247899Z","2026-05-05T02:43:28.962637Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":131,"content_modified":132},"NCT06140719","xPedite: A Study to Expedite DIPG and DMG Research",[],"2026-08-26T02:18:15.214990Z","2026-05-13T02:55:06.417556Z",{"nct_id":134,"title":135,"phases":136,"status":13,"updated_at":137,"content_modified":138},"NCT03101813","International Diffuse Intrinsic Pontine Glioma (DIPG)\u002FDiffuse Midline Glioma (DMG) Registry and Repository",[],"2026-08-26T02:16:44.178623Z","2026-05-13T02:55:06.107366Z",{"nct_id":140,"title":141,"phases":142,"status":13,"updated_at":143,"content_modified":144},"NCT06860594","Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma",[20],"2026-08-26T02:18:58.141497Z","2026-06-14T18:39:22.242053Z",{"nct_id":146,"title":147,"phases":148,"status":13,"updated_at":149,"content_modified":150},"NCT05839379","Targeted Pediatric High-Grade Glioma Therapy",[],"2026-08-26T02:18:20.384845Z","2026-05-13T02:55:06.380433Z",{"nct_id":152,"title":153,"phases":154,"status":13,"updated_at":155,"content_modified":156},"NCT06000787","MCT for the Harvard\u002FUCSF ROBIN Center",[],"2026-08-26T02:18:13.438956Z","2026-05-05T02:43:28.172535Z",{"nct_id":158,"title":159,"phases":160,"status":161,"updated_at":162,"content_modified":163},"NCT07389278","Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)",[63],"NOT_YET_RECRUITING","2026-08-26T02:18:12.612955Z","2026-05-05T02:43:28.503578Z",{"nct_id":165,"title":166,"phases":167,"status":168,"updated_at":169,"content_modified":170},"NCT06896110","Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma",[20],"ENROLLING_BY_INVITATION","2026-08-26T02:15:00.557154Z","2026-06-16T05:54:07.840721Z",{"nct_id":172,"title":173,"phases":174,"status":175,"updated_at":176,"content_modified":177},"NCT05835687","Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors",[20],"ACTIVE_NOT_RECRUITING","2026-08-03T03:23:28.660374Z","2026-05-05T02:43:27.753658Z",[179,183,187,191],{"biomarker":180,"count":181,"slug":182},"H3 K27M Variant",9,"h3-k27m-variant",{"biomarker":184,"count":185,"slug":186},"Histone H3 Lysine 28",7,"histone-h3-lysine-28",{"biomarker":188,"count":189,"slug":190},"RELAXIN 3",4,"relaxin-3",{"biomarker":192,"count":193,"slug":194},"IDH1 wt Allele",3,"idh1-wt-allele",[196,200,204,207,210,213,216,219,222,226,229,232,235,238,241,245,248,251,254,257,260,263,266,269],{"state":197,"count":198,"slug":199},"California",11,"california",{"state":201,"count":202,"slug":203},"Pennsylvania",8,"pennsylvania",{"state":205,"count":185,"slug":206},"District of Columbia","district-of-columbia",{"state":208,"count":185,"slug":209},"Illinois","illinois",{"state":211,"count":185,"slug":212},"Missouri","missouri",{"state":214,"count":185,"slug":215},"New York","new-york",{"state":217,"count":185,"slug":218},"Ohio","ohio",{"state":220,"count":185,"slug":221},"Texas","texas",{"state":223,"count":224,"slug":225},"Georgia",6,"georgia",{"state":227,"count":224,"slug":228},"Massachusetts","massachusetts",{"state":230,"count":224,"slug":231},"Michigan","michigan",{"state":233,"count":224,"slug":234},"Minnesota","minnesota",{"state":236,"count":224,"slug":237},"North Carolina","north-carolina",{"state":239,"count":224,"slug":240},"Washington","washington",{"state":242,"count":243,"slug":244},"Tennessee",5,"tennessee",{"state":246,"count":189,"slug":247},"Alabama","alabama",{"state":249,"count":189,"slug":250},"Colorado","colorado",{"state":252,"count":189,"slug":253},"Indiana","indiana",{"state":255,"count":189,"slug":256},"Maryland","maryland",{"state":258,"count":189,"slug":259},"Utah","utah",{"state":261,"count":193,"slug":262},"Arizona","arizona",{"state":264,"count":193,"slug":265},"Florida","florida",{"state":267,"count":193,"slug":268},"New Jersey","new-jersey",{"state":270,"count":193,"slug":271},"Wisconsin","wisconsin"]